Regulation 6(2)(b)
SCHEDULE 4Substitution of entry in Table 1 in the Annex to Commission Implementing Regulation (EU) 2017/2470 for Bovine milk basic whey protein isolate
| “Bovine milk basic whey protein isolate | Specified food category Infant formula as defined in Regulation (EU) No. 609/2013(1) Follow-on formula as defined in Regulation (EU) No. 609/2013 Total diet replacement for weight control as defined in Regulation (EU) No. 609/2013 Foods for special medical purposes as defined in Regulation (EU) No. 609/2013 Food supplements as defined in the Food Supplements (England) Regulations 2003 | Maximum levels 30 mg/ 100g (powder 3.9 mg/100 ml (reconstituted) 30 mg/ 100 g (powder) 4.2 mg/100 ml (reconstituted) 300 mg/day 30 mg/100 g (powder formula for infants (persons under the age of 1 year (12 months)) during first months of life until the introduction of appropriate complementary feeding) 3.9 mg/100 ml (reconstituted formula for infants during the first months of life until the introduction of appropriate complementary feeding) 30 mg/100 g (powder formula for infants when appropriate complementary feeding is introduced) 4.2 mg/100 ml (reconstituted formula for infants when appropriate complementary feeding is introduced) 58 mg/day for young children (persons aged between 1 year (12 months) up to the age of 3 years (36 months)) 380 mg/day for children and adolescents (aged 3 years (36 months) to 18 years of age) 610 mg/day for persons aged 18 years or above 25 mg/day for infants (persons under the age of 1 year (12 months)) 58 mg/day for young children (persons aged 1 year (12 months) up to the age of 3 years (36 months)) 250 mg/day for children and adolescents (aged 3 years (36 months) to 18 years of age) 610 mg/day for persons aged 18 years or above | The designation of the novel food on the labelling of food containing it is “Milk whey protein isolate”. The labelling of food supplements must bear a statement, as appropriate, that they should not be consumed by infants (persons under the age of 1 year)/infants or young children (persons under the age of 3 years)/infants, children or adolescents (persons under the age of 18 years).” |
EUR 2015/2283, amended by S.I. 2019/702; there are other amending instruments but none is relevant. The terms “prescribe”, “appropriate authority”, and “list” are defined in Article 3. Article 12(1) applies in accordance with Articles 9 and 27(1).